Related Experiment Video
Updated: Jul 8, 2026
03:45
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Psychiatric disorders in hypertrophic cardiomyopathy
John F Morgan1, Ann C O'Donoghue, William J McKenna
1Department of Psychiatry, Yorkshire Centre for Eating Disorders, Seacroft Hospital, LS14 6UH LEEDS, UK. john.morgan@leedsmh.nhs.uk <john.morgan@leedsmh.nhs.uk>
General Hospital Psychiatry
|January 1, 2008
Summary
Patients with hypertrophic cardiomyopathy have high rates of anxiety and mood disorders. Chest pain, older age, and perceived risk of death are key risk factors for these conditions.
Area of Science:
- Cardiology
- Psychiatry
- Epidemiology
Background:
- Depression is frequently undertreated in patients with cardiac disease.
- Hypertrophic cardiomyopathy (HCM) patients may have undiagnosed psychiatric conditions.
- Understanding psychiatric disorder prevalence in HCM is crucial for patient care.
Purpose of the Study:
- To determine the frequency of psychiatric disorders in patients with hypertrophic cardiomyopathy.
- To identify demographic and clinical risk factors associated with mood and anxiety disorders in HCM.
- To inform treatment strategies for improving quality of life in HCM patients.
Main Methods:
- A two-phase epidemiological study involving 148 adult HCM patients.
- Screening for psychiatric morbidity using the Hospital Anxiety and Depression Scale and Social Adjustment Scale.
- Diagnostic confirmation via Structured Clinical Interview for DSM-III-R for likely cases.
Main Results:
- 37% of HCM patients met criteria for an anxiety disorder; 21% for a mood disorder.
- Mood disorder associated with chest pain, older age, perceived risk of death, poor social adjustment, and sexual problems.
- Anxiety disorders linked to chest pain, perceived risk of death, symptom severity perception, and recent diagnosis.
Conclusions:
- Patients with hypertrophic cardiomyopathy exhibit elevated risks for mood and anxiety disorders.
- Specific demographic and clinical factors are significantly associated with these psychiatric conditions.
- Targeted interventions can potentially enhance the quality of life for HCM patients.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...